Helen L Zhang
Overview
Explore the profile of Helen L Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang H, Nemeth H, Woodhouse E, Davenport C, Chan C, Okeke N, et al.
J Viral Hepat
. 2024 Oct;
31(12):866-872.
PMID: 39360629
A subset of patients with chronic hepatitis C virus (HCV) infection demonstrate liver enzyme elevation (LEE) after achieving sustained virologic response (SVR). Risk factors for LEE are not well characterised....
2.
Zhang H, Mock M, Bushman L, Anderson P, Kiser J, Naggie S
Clin Infect Dis
. 2024 May;
79(3):705-708.
PMID: 38703389
This case-control study explored cumulative tenofovir exposure among patients with human immunodeficiency virus/hepatis B virus (HIV/HBV) coinfection with HIV viral suppression. Among patients taking tenofovir disoproxil fumarate, median TFV-DP levels...
3.
Zhang H, Perez R, Krishnan J, Lautenbach E, Anderson D
Open Forum Infect Dis
. 2023 Dec;
10(12):ofad561.
PMID: 38130594
Background: Extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) are an increasingly important cause of community-onset urinary tract infections (UTIs), including recurrent infections. We evaluated risk factors for recurrence among patients with community-onset ESCrE...
4.
Zhang H, Crane L, Cromer A, Green A, Padgette P, Payne V, et al.
Infect Control Hosp Epidemiol
. 2023 Aug;
45(1):103-105.
PMID: 37589089
We calculated the attributable cost of several healthcare-associated infections in a community hospital network: central-line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), hospital-onset infections (CDI-HOs) (43 hospitals); surgical site...
5.
Zhang H, Han J, Lapp Z, Snitkin E, Goldstein E, Muldoon S, et al.
Open Forum Infect Dis
. 2022 Sep;
9(9):ofac452.
PMID: 36168553
We assessed risk factors for colistin resistance among carbapenem-resistant (CRKP) from 375 patients in long-term acute care hospitals. Recent colistin or polymyxin B exposure was associated with increased odds of...
6.
Zhang H, Anesi J, Hamilton K, Cressman L, Bilker W, Lautenbach E
Open Forum Infect Dis
. 2022 Aug;
9(8):ofac384.
PMID: 35983261
Background: Reported β-lactam allergies (BLAs) are common and frequently inaccurate, but there are limited data on the clinical implications of BLA among solid organ transplant (SOT) recipients. We examined the...
7.
Zhang H, Gontjes K, Han J, Alby K, Lapp Z, Snitkin E, et al.
Infect Control Hosp Epidemiol
. 2022 Jul;
44(7):1159-1162.
PMID: 35896514
We assessed susceptibility patterns to newer antimicrobial agents among clinical carbapenem-resistant (CRKP) isolates from patients in long-term acute-care hospitals (LTACHs) from 2014 to 2015. Meropenem-vaborbactam and imipenem-relebactam nonsusceptibility were observed...
8.
Zhang H, Kelly B, David M, Lautenbach E, Huang E, Bekele S, et al.
Am J Infect Control
. 2022 Feb;
50(4):462-464.
PMID: 35108581
We evaluated the effect of terminal cleaning on SARS-CoV-2 RNA contamination of COVID-19 isolation rooms in an acute care hospital. SARS-CoV-2 RNA was detected on 32.1% of room surfaces after...
9.
Zhang H, Kelly B, David M, Lautenbach E, Huang E, Bekele S, et al.
Infect Control Hosp Epidemiol
. 2021 Nov;
44(1):110-113.
PMID: 34776022
We prospectively surveyed SARS-CoV-2 RNA contamination in staff common areas within an acute-care hospital. An increasing prevalence of surface contamination was detected over time. Adjusting for patient census or community...
10.
Zhang H, Cressman L, Lautenbach E
J Glob Antimicrob Resist
. 2021 Nov;
27:299-302.
PMID: 34775130
Objectives: Real-world data regarding the effectiveness of meropenem/vaborbactam (MVB) in the treatment of carbapenem-resistant Enterobacterales (CRE) infections remain limited. In this retrospective case series, we describe the outcomes of patients...